Last Updated on eMC 21-12-2016 View medicine  | Takeda UK Ltd Contact details

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC.  For each version, we show the dates it was published on the eMC and the reasons for change.

Reasons for adding or updating:

  • Change to section 6 - manufacturer

Reasons for adding or updating:

  • Change to section 6 - marketing authorisation holder
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 4 - possible side effects
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision

Reasons for adding or updating:

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 5 - how to store
  • Change to section 6 - what the product contains
  • Change to section 6 - manufacturer
  • Change to section 6 - date of revision
  • Addition of black triangle

Reasons for adding or updating:

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 5 - how to store
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision
  • Removal of black triangle

Reasons for adding or updating:

  • Change to section 2 - pregnancy, breast feeding and fertility
  • Change to section 3 - how to take/use
  • Change to section 5 - how to store
  • Change to section 6 - what the product contains
  • Change to section 6 - date of revision
  • Addition of black triangle

Reasons for adding or updating:

  • Change to section 6 - what the product looks like and pack contents
  • Change to section 6 - marketing authorisation holder

Reasons for adding or updating:

  • New PIL for new product